Abstract
Limbal stem cell deficiency (LSCD) is a clinical condition characterized by damage of cornea limbal stem cells, which results in an impairment of corneal epithelium turnover and in an invasion of the cornea by the conjunctival epithelium. In these patients, the conjunctivalization of the cornea is associated with visual impairment and cornea transplantation has poor prognosis for recurrence of the conjunctivalization. Current treatments of LSCD are aimed at replacing the damaged corneal stem cells in order to restore a healthy corneal epithelium. The autotransplantation of limbal tissue from the healthy, fellow eye is effective in unilateral LSCD but leads to depauperation of the stem cell reservoir. In the last decades, novel techniques such as cultivated limbal epithelial transplantation (CLET) have been proposed in order to reduce the damage of the healthy fellow eye. Clinical and experimental evidence showed that CLET is effective in inducing long-term regeneration of a healthy corneal epithelium in patients with LSCD with a success rate of 70%–80%. Current limitations for the treatment of LSCD are represented by the lack of a marker able to unequivocally identify limbal stem cells and the treatment of total, bilateral LSCD which requires other sources of stem cells for ocular surface reconstruction.
Highlights
The human cornea, which covers the anterior part of the ocular globe as a transparent dome, has an avascular, stratified, nonkeratinized squamous epithelium
Since the first report in 1997 by Pellegrini et al, the efficacy of cultivated limbal epithelial transplantation (CLET) to regenerate the ocular surface has been demonstrated in many reports [31, 81,82,83]
Baylis and colleagues recently reviewed the outcomes of cultured epithelial cell therapy over the past 13 years [63]
Summary
The human cornea, which covers the anterior part of the ocular globe as a transparent dome, has an avascular, stratified, nonkeratinized squamous epithelium. In 1997, Pellegrini et al showed that autologous cultivated limbal epithelial transplantation (CLET) obtained from a 1 mm2 limbal biopsy included stem cells and restored the corneal surface in two patients with complete loss of the corneal-limbus epithelium [31] (Figure 3(b)).
Sign-in/Register to view highlights & summary Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
